Sign In  |  Register  |  About Daly City  |  Contact Us

Daly City, CA
September 01, 2020 1:20pm
7-Day Forecast | Traffic

  • Search Hotels in Daly City

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Silk Road Medical, Inc. - Common Stock (NQ: SILK )

27.49 UNCHANGED
Last Price Updated: 4:00 PM EDT, Sep 16, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Silk Road Medical, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
Beyond QQQ: Two Nasdaq ETFs For Finding Potential Future Tech Superstars
The top 10 positions in QQQ constitute almost half of its total weight. Although current tech leaders may have become too pricey two Invesco Nasdaq ETFs target future tech leaders: QQQJ and QQQS. Both... 
Via Talk Markets
Topics ETFs
SILK Stock Earnings: Silk Road Medical Misses EPS, Beats Revenue for Q2 2024
SILK stock results show that Silk Road Medical missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. 
Via InvestorPlace
A Closer Look at 4 Analyst Recommendations For Silk Road Medical
Via Benzinga
3 Record-Breaking Stocks With More Room to Run
These three top record-breaking stocks have more upside ahead, driven by analysts' Strong Buy recommendations. 
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Evaluating Silk Road Medical: Insights From 6 Financial Analysts
Via Benzinga
Breaking Down Silk Road Medical: 5 Analysts Share Their Views
Via Benzinga
Silk Road Medical: Q4 Earnings Insights
Via Benzinga
Expert Outlook: Silk Road Medical Through The Eyes Of 5 Analysts
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Why Quantum Shares Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Recap: Silk Road Medical Q3 Earnings
Via Benzinga
Patterson Companies, Silk Road Medical, Micron, Hewlett Packard Enterprise And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
TSLA Stock Alert: Tesla Sues Battery Supplier Matthews International
Tesla stock is down on Tuesday after TSLA investors learned of a new lawsuit against former battery supplier Matthews International. 
Via InvestorPlace
Topics Lawsuit Supply Chain
Exposures Financial Legal Supply Chain
Boston Scientific Adds Stroke Prevention To Vascular Portfolio Via Silk Road Medical's $1.3B Deal
Boston Scientific to acquire Silk Road Medical for $1.26 billion, enhancing its vascular portfolio with Silk Road's TCAR system, a breakthrough in stroke prevention. Transaction closes in H2 2024. 
Via Benzinga
Chegg Layoffs 2024: What to Know About the Latest Chegg Job Cuts
Chegg layoffs have the company cutting hundreds of jobs and closing multiple offices as part of a larger restructuring. 
Via InvestorPlace
Topics Workforce
Exposures Layoff
Why Is Silk Road Medical (SILK) Stock Up 24% Today?
Silk Road Medical stock is up on Tuesday after Boston Scientific announced its acquiring the company in a $1.26 billion deal. 
Via InvestorPlace
Silk Road Medicine Rockets On Boston Scientific's $1.16 Billion Takeover
The deal focuses on the company's stroke prevention product for patients with carotid artery disease. 
Via Investor's Business Daily
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
It's time to start the day with a breakdown of the biggest pre-market stock movers worth keeping an eye on for Tuesday morning! 
Via InvestorPlace
SILK Stock Earnings: Silk Road Medical Beats EPS, Beats Revenue for Q1 2024
SILK stock results show that Silk Road Medical beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
Top 3 Health Care Stocks You May Want To Dump In Q1
As of Feb. 29, 2024, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. 
Via Benzinga
Earnings Scheduled For February 28, 2024
Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings at $0.08 per share on revenue of $1.69 billion. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Heart Devices Focused Silk Road Medical Stock Gets an Upgrade - Analyst Says New CEO's Initiatives Sets Stage For 'Back On Track'
Stifel's upgraded outlook on Silk Road Medical as CEO Chas McKhann addresses concerns, unveils a compelling vision, and outlines strategic initiatives. Analysts upgrade to Buy with $20 price target,... 
Via Benzinga
Why TransCode Therapeutics Shares Are Trading Lower By Over 24%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of TransCode Therapeutics, Inc. (NASDAQ: RNAZ) fell sharply during Friday’s session. TransCode Therapeutics priced a 5,942,623 share common stock offering at $1.22 per share. TransCode... 
Via Benzinga
World Acceptance Posts Upbeat Earnings, Joins Kaman, Spirit Airlines And Other Big Stocks Moving Higher On Friday
U.S. stocks traded higher, with the Dow Jones index gaining around 50 points on Friday. Shares of World Acceptance Corporation (NASDAQ: WRLD) rose sharply during Friday’s session following upbeat... 
Via Benzinga
Topics Stocks
Exposures US Equities
Texas Instruments To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Friday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
Via Benzinga
Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of RxSight, Inc. (NASDAQ: RXST) rose sharply during Monday’s session after the company issued preliminary FY23 and FY24 revenue guidance above estimates. Also, Needham maintained a Buy rating on... 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 DalyCity.com & California Media Partners, LLC. All rights reserved.